Si-Bone (SIBN) Consolidated Net Income (2017 - 2026)
Si-Bone's (SIBN) quarterly Consolidated Net Income came in at -$18.4 million in Q1 2026, down 180.81% year-on-year from $22.8 million in Q1 2025, and down 1017.44% quarter-over-quarter from -$1.6 million in Q4 2025.
Si-Bone (SIBN) Consolidated Net Income (2017 - 2026) Analysis & Trends
Si-Bone's Consolidated Net Income history runs 10 years deep, the most recent figure standing at -$18.4 million for Q1 2026.
- On a quarterly basis, Consolidated Net Income fell 180.81% year-over-year to -$18.4 million in Q1 2026; TTM through Mar 2026 was -$5.4 billion, a 19199.97% decrease from a year earlier, with the FY2025 full-year figure at -$127.4 million, up 9.39% from the prior year.
- Consolidated Net Income slipped to -$18.4 million in Q1 2026 per SIBN's latest filing, from -$1.6 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at -$1.6 million in Q4 2025 and bottomed at -$5.4 billion in Q3 2025.
- The 5-year median for Consolidated Net Income is -$11.2 million (2023), against an average of -$326.0 million.
- Biggest YoY gain for Consolidated Net Income was 72.03% in 2025; the steepest drop was 81390.17% in 2025.
- Year by year, Consolidated Net Income stood at -$12.2 million in 2022, then declined by 1.17% to -$12.3 million in 2023, then soared by 52.17% to -$5.9 million in 2024, then surged by 72.03% to -$1.6 million in 2025, then tumbled by 1017.44% to -$18.4 million in 2026.
- Per Business Quant, the three latest SIBN Consolidated Net Income figures stand at -$18.4 million (Q1 2026), -$1.6 million (Q4 2025), and -$5.4 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.40 Bn | 176.11 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 68.71 Bn | 67.25 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 273.95 Mn |
| 10 | Si-Bone | 752.59 Mn | 607.91 Mn | 41.94 Mn | -18.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.39 Mn |
| Dec 31, 2025 | -1.65 Mn |
| Sep 30, 2025 | -5.36 Bn |
| Jun 30, 2025 | -13.17 Mn |
| Mar 31, 2025 | -6.55 Mn |
| Dec 31, 2024 | -5.89 Mn |
| Sep 30, 2024 | -6.58 Mn |
| Jun 30, 2024 | -8.94 Mn |
| Mar 31, 2024 | -10.81 Mn |
| Dec 31, 2023 | -12.31 Mn |
| Sep 30, 2023 | -9.88 Mn |
| Jun 30, 2023 | -11.23 Mn |
| Mar 31, 2023 | -11.20 Mn |
| Dec 31, 2022 | -12.16 Mn |
| Sep 30, 2022 | -13.98 Mn |
| Jun 30, 2022 | -18.37 Mn |
| Mar 31, 2022 | -17.36 Mn |
| Dec 31, 2021 | -18.43 Mn |
| Sep 30, 2021 | -15.81 Mn |
| Jun 30, 2021 | -13.99 Mn |